213 related articles for article (PubMed ID: 30098724)
1. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
Sorbye H; Baudin E; Perren A
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
[TBL] [Abstract][Full Text] [Related]
2. PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms.
Grass A; Kasajima A; Foersch S; Kriegsmann M; Brobeil A; Schmitt M; Wagner D; Poppinga J; Wiese D; Maurer E; Kirschbaum A; Muley T; Winter H; Rinke A; Gress TM; Kremer M; Evert M; Märkl B; Quaas A; Eckstein M; Tschurtschenthaler M; Klöppel G; Denkert C; Bartsch DK; Jesinghaus M
Mod Pathol; 2024 Apr; 37(4):100442. PubMed ID: 38309431
[TBL] [Abstract][Full Text] [Related]
3. A new era for the systemic therapy of neuroendocrine tumors.
Eads JR; Meropol NJ
Oncologist; 2012; 17(3):326-38. PubMed ID: 22357730
[TBL] [Abstract][Full Text] [Related]
4. Updates on Urinary Bladder Tumors With Neuroendocrine Features.
Akbulut D; Al-Ahmadie H
Adv Anat Pathol; 2024 May; 31(3):169-177. PubMed ID: 38523484
[TBL] [Abstract][Full Text] [Related]
5. Well Differentiated Grade 3 Neuroendocrine Tumors of the Digestive Tract: A Narrative Review.
Pellat A; Coriat R
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492939
[TBL] [Abstract][Full Text] [Related]
6. An Illustrated Review of the Recent 2019 World Health Organization Classification of Neuroendocrine Neoplasms: A Radiologic and Pathologic Correlation.
Ursprung S; Zhang ML; Asmundo L; Hesami M; Najmi Z; Cañamaque LG; Shenoy-Bhangle AS; Pierce TT; Mojtahed A; Blake MA; Cochran R; Nikolau K; Harisinghani MG; Catalano OA
J Comput Assist Tomogr; 2024 Feb; ():. PubMed ID: 38438338
[TBL] [Abstract][Full Text] [Related]
7. Poorly differentiated orbital neuroendocrine carcinoma.
Zhang YS; Jiro M; Pekmezci M; Winn B
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37648277
[TBL] [Abstract][Full Text] [Related]
8. Changes in categorization or nomenclature within Neuroendocrine Tumours.
Vocino Trucco G; Volante M
Endocr Relat Cancer; 2024 May; ():. PubMed ID: 38776393
[TBL] [Abstract][Full Text] [Related]
9. Mixed neuroendocrine non-neuroendocrine neoplasms in gastroenteropancreatic tract.
Díaz-López S; Jiménez-Castro J; Robles-Barraza CE; Ayala-de Miguel C; Chaves-Conde M
World J Gastrointest Oncol; 2024 Apr; 16(4):1166-1179. PubMed ID: 38660639
[TBL] [Abstract][Full Text] [Related]
10. Molecular studies of lung neuroendocrine neoplasms uncover new concepts and entities.
Fernandez-Cuesta L; Foll M
Transl Lung Cancer Res; 2019 Dec; 8(Suppl 4):S430-S434. PubMed ID: 32038931
[No Abstract] [Full Text] [Related]
11. Differentiating high-grade neuroendocrine neoplasms.
Taboada RG; Riechelmann RP
Nat Rev Cancer; 2024 Apr; 24(4):233. PubMed ID: 38291173
[No Abstract] [Full Text] [Related]
12. Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3).
Sorbye H; Baudin E; Borbath I; Caplin M; Chen J; Cwikla JB; Frilling A; Grossman A; Kaltsas G; Scarpa A; Welin S; Garcia-Carbonero R;
Neuroendocrinology; 2019; 108(1):54-62. PubMed ID: 30153658
[TBL] [Abstract][Full Text] [Related]
13. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.
Rindi G; Klimstra DS; Abedi-Ardekani B; Asa SL; Bosman FT; Brambilla E; Busam KJ; de Krijger RR; Dietel M; El-Naggar AK; Fernandez-Cuesta L; Klöppel G; McCluggage WG; Moch H; Ohgaki H; Rakha EA; Reed NS; Rous BA; Sasano H; Scarpa A; Scoazec JY; Travis WD; Tallini G; Trouillas J; van Krieken JH; Cree IA
Mod Pathol; 2018 Dec; 31(12):1770-1786. PubMed ID: 30140036
[TBL] [Abstract][Full Text] [Related]
14. Gastroenteropancreatic Neuroendocrine Tumors.
Cives M; Strosberg JR
CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
[TBL] [Abstract][Full Text] [Related]
15. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Pavel M; Öberg K; Falconi M; Krenning EP; Sundin A; Perren A; Berruti A;
Ann Oncol; 2020 Jul; 31(7):844-860. PubMed ID: 32272208
[No Abstract] [Full Text] [Related]
16. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms.
Mafficini A; Scarpa A
Endocr Rev; 2019 Apr; 40(2):506-536. PubMed ID: 30657883
[TBL] [Abstract][Full Text] [Related]
17. A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
Elvebakken H; Perren A; Scoazec JY; Tang LH; Federspiel B; Klimstra DS; Vestermark LW; Ali AS; Zlobec I; Myklebust TÅ; Hjortland GO; Langer SW; Gronbaek H; Knigge U; Tiensuu Janson E; Sorbye H
Neuroendocrinology; 2021; 111(9):883-894. PubMed ID: 33002892
[TBL] [Abstract][Full Text] [Related]
18. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.
Nielsen K; Binderup T; Langer SW; Kjaer A; Knigge P; Grøndahl V; Melchior L; Federspiel B; Knigge U
BMC Cancer; 2020 Jan; 20(1):27. PubMed ID: 31924180
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas.
Patel N; Barbieri A; Gibson J
Surg Pathol Clin; 2019 Dec; 12(4):1021-1044. PubMed ID: 31672292
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
Siddiqa A; Adel H; Khan SA; Huda F; Sattar A
J Pak Med Assoc; 2019 Apr; 69(4):533-540. PubMed ID: 31000859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
